Condition: Areata Alopecia · Alopecia · Hypotrichosis · Sponsor: Eli Lilly and Company
The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension (LTE) Period, and a 4-week Post-treatment Follow-up period. Some individuals may be eligible to receive treatment after completing the LTE, for a maximum of 180 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Total Skin and Beauty Dermatology Center, PC | Birmingham, Alabama, United States | Recruiting |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Not Yet Recruiting |
| Investigate MD | Scottsdale, Arizona, United States | Recruiting |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | Not Yet Recruiting |
| Dermatology Research Associates | Los Angeles, California, United States | Recruiting |
| University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology | San Diego, California, United States | Recruiting |
| The Permanente Medical Group, Inc. | San Francisco, California, United States | Recruiting |
| Southern California Dermatology, Inc. | Santa Ana, California, United States | Recruiting |
| Dermatology Physicians of Connecticut | Fairfield, Connecticut, United States | Not Yet Recruiting |
| Skin Care Research, Inc | Boca Raton, Florida, United States | Not Yet Recruiting |
| Florida Academic Centers Research and Education, LLC | Coral Gables, Florida, United States | Completed |
| D&H Doral Research Center LLC | Doral, Florida, United States | Not Yet Recruiting |
+ 115 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05723198